Frontlight ResearchEarly access
Myelodysplastic syndromes trials in United States
224 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleMetabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- Where
- Sacramento, The Bronx, White Plains
- Age
- 18 years and over
- People
- 91
- Run by
- Montefiore Medical Center
See details and how to joinNCT05184842 - Phase 1Taking peopleStudy of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- Where
- Atlanta, Baltimore, Jacksonville, Miami, Orlando, Tampa, The Bronx
- Age
- 18 years and over
- People
- 151
- Run by
- Syntrix Biosystems, Inc.
See details and how to joinNCT04245397 - No phaseTaking peopleHome Blood Transfusions
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 30
- Run by
- Thomas Jefferson University
See details and how to joinNCT07121140 - Phase 1/2Taking peopleClinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
- Where
- Charlotte, Houston, Winston-Salem
- Age
- 18 years and over
- People
- 49
- Run by
- ARCE Therapeutics, Inc.
See details and how to joinNCT06680752 - Phase 2Taking peopleExercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
- Where
- Duarte, Memphis, Philadelphia
- Age
- 10 years to 30 years
- People
- 80
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT05194397 - Phase 2Taking peopleHSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- Where
- Cincinnati, New York, Seattle
- Age
- 3 months and over
- People
- 70
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT02143830 - No phaseTaking peopleActivity Levels in Bone Marrow Transplant Patients
- Where
- Iowa City
- Age
- 18 years to 99 years
- People
- 200
- Run by
- Michael Tomasson
See details and how to joinNCT04115241 - Phase 2Taking peopleTwo Step Haplo With Radiation Conditioning
- Where
- Philadephia
- Age
- 18 years and over
- People
- 63
- Run by
- Thomas Jefferson University
See details and how to joinNCT05031897 - No phaseTaking peopleSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Where
- Albuquerque, Ann Arbor, Atlanta, Aurora, Baltimore, Bethesda, Billings, Birmingham, Boise, Buffalo, Chapel Hill, Charlottesville, Chicago, Cincinnati, Columbus, Dallas, Denver, Duarte, Duluth, Fargo, Greenville, Hartford, Hattiesburg, Hempstead, Houston, Iowa City, Irvine, Jacksonville, Kansas City, La Jolla, Lansing, Little Rock, Littleton, Manhasset, Mayfield Heights, Memphis, Miami, Milwaukee, Mobile, Morgantown, Nashville, Newark, New Brunswick, New Orleans, New York, Norwalk, Omaha, Orange, Philadelphia, Portland, Providence, Salt Lake City, San Francisco, Savannah, Scarborough, Scottsdale, Seattle, Silver Spring, Stanford, Staten Island, St Louis, Tampa, Temple, Towson, Tulsa, Winston-Salem, Worcester
- People
- 50,000 worldwide
- Run by
- Massive Bio, Inc.
See details and how to joinNCT03452774 - Phase 1Taking peopleIS-free Treg HaploHCT
- Where
- Boston
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04678401 - No phaseTaking peopleUmbilical Cord Blood Transplantation From Unrelated Donors
- Where
- Rochester
- Age
- 2 months to 75 years
- People
- 30
- Run by
- University of Rochester
See details and how to joinNCT03016806 - Phase 1Taking peopleQ702 for the Treatment of Patients With Hematologic Malignancies
- Where
- Rochester, Scottsdale
- Age
- 18 years and over
- People
- 46
- Run by
- Mayo Clinic
See details and how to joinNCT06712810 - Phase 1/2Not yet taking people in United StatesAB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Where
- Houston
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- AB Science
See details and how to joinNCT05211570 · EU 2024-516641-39-00 - Phase 1Taking peopleA Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
- Where
- Buffalo, Chicago, Columbus, Duarte, Houston, Los Angeles, Madison, Miami, Nashville, New York, Palo Alto, Seattle, Tampa
- Age
- 18 years and over
- People
- 170
- Run by
- BlossomHill Therapeutics
See details and how to joinNCT06501196 - Phase 1/2Taking peopleClinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Atlanta, Birmingham, Boston, Cleveland, Columbus, Duarte, Durham, Huston, Irvine, La Jolla, Los Angeles, Miami, New Haven, Palo Alto, Sacramento
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Aptose Biosciences Inc.
See details and how to joinNCT03850574 · EU 2023-503244-14-00 - No phaseTaking peopleShwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
- Where
- Woburn
- People
- 8,000
- Run by
- Shwachman-Diamond Syndrome Alliance Inc
See details and how to joinNCT06999954 - Phase 2Enrolling by invitationKIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
- Where
- Chicago, Los Angeles, Milwaukee, Nashville, Oakland, Palo Alto, Philadelphia, Salt Lake City, San Diego, San Francisco, Valhalla
- Age
- Up to 21 years
- People
- 50
- Run by
- Michael Pulsipher
See details and how to joinNCT02646839 - Phase 1Taking peoplePrevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Where
- Boston, Duarte, Minneapolis, New York, Seattle
- Age
- 18 years and over
- People
- 36
- Run by
- Tr1X, Inc.
See details and how to joinNCT06462365 - Phase 2Taking peopleA Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
- Where
- Aurora, Bethesda, Canton, Chapel Hill, Charleston, Columbia, Columbus, Dallas, Eugene, Los Angeles, New Haven, Orange City, St Louis, The Bronx
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- Akeso
See details and how to joinNCT06196203 - Phase 1Taking peopleStudy of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
- Where
- Birmingham, Cincinnati, Houston, Nashville, Seattle
- Age
- 18 years and over
- People
- 36
- Run by
- Vincerx Pharma, Inc.
See details and how to joinNCT06034275 - No phaseTaking peopleThe International PNH Interest Group PNH Registry
- Where
- Altamonte Springs
- People
- 2,000
- Run by
- International PNH Interest Group
See details and how to joinNCT06524726 - Phase 1Taking peopleA Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Where
- Duarte, Houston, New York
- Age
- 18 years and over
- People
- 80
- Run by
- Edgewood Oncology Inc.
See details and how to joinNCT04243785 - Phase 1Taking peopleStudy in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
- Where
- Fairway, Jacksonville
- Age
- 18 years and over
- People
- 27 worldwide
- Run by
- Celyad Oncology SA
See details and how to joinNCT04167696 - Phase 1/2Taking peopleA Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- Where
- Tampa
- Age
- 18 years and over
- People
- 47
- Run by
- Lixte Biotechnology Holdings, Inc.
See details and how to joinNCT03886662